Login / Signup

Liver injury, SARS-COV-2 infection and COVID-19: What physicians should really know?

Anna LicataMaria Giovanna MinissaleMarco DistefanoGiuseppe Montalto
Published in: GastroHep (2021)
Mild to moderate liver impairment during Covid-19 is common, especially in patients with pre-existing liver disease. Further studies should be performed in order to understand how pre-existing liver conditions may influence and worsen progression of liver disease in COVID-19 patients.
Keyphrases
  • liver injury
  • drug induced
  • sars cov
  • coronavirus disease
  • respiratory syndrome coronavirus
  • primary care
  • case control